Retinoblastoma mutation predicts poor outcomes in advanced non small cell lung cancer-Reference-Cited by-同舟云学术

Retinoblastoma mutation predicts poor outcomes in advanced non small cell lung cancer

Published:2019-02-17 Issue:4 Volume:8 Page:1459-1466
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Bhateja Priyanka¹,Chiu Michelle²,Wildey Gary²^ORCID,Lipka Mary Beth³,Fu Pingfu⁴,Yang Michael Chiu Lee⁵,Ardeshir‐Larijani Fatemeh⁶,Sharma Neelesh⁷,Dowlati Afshin¹

Affiliation:

1. Department of Hematology and Oncology Case Western Reserve University University Hospitals Seidman Cancer Center Cleveland Ohio

2. School of Medicine Case Western Reserve University Cleveland Ohio

3. Department of Hematology and Oncology University Hospitals Seidman Cancer Center Cleveland Ohio

4. Department of Population and Quantitative Health Sciences Case Western Reserve University Cleveland Ohio

5. Department of Pathology University Hospitals Cleveland Medical Center Cleveland Ohio

6. Department of Internal Medicine University Hospitals Cleveland Medical Center Cleveland Ohio

7. Department of Biomedical Research Novartis Pharmaceuticals Corporation East Hanover New Jersey

Funder

University Hospitals

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2023

Reference36 articles.

1. Chipping away at the lung cancer genome

2. The BATTLE-2 Study: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer

3. STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma

4. Clinical and Molecular Characteristics of NF1-Mutant Lung Cancer

5. Comprehensive molecular profiling of lung adenocarcinoma

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-Grade, Nonsarcomatoid Chromophobe Renal Cell Carcinoma: A Series of 22 Cases With Novel Molecular Features on a Subset;Modern Pathology;2024-05

2. Genetic and Epigenetic Dysregulation in Environmental Disease;Comprehensive Precision Medicine;2024

3. Mutant RB1 enhances therapeutic efficacy of PARPis in lung adenocarcinoma by triggering the cGAS/STING pathway;JCI Insight;2023-11-08

4. The role of alternative pre-mRNA splicing in cancer progression;Cancer Cell International;2023-10-24

5. Prognostic and predictive impact of molecular tumor burden index in non‐small cell lung cancer patients;Thoracic Cancer;2023-09-19